enstilar 50 mikrog/g + 0,5 mg/g ihovaahto
leo pharma a/s - betamethasone dipropionate, calcipotriol hydrate - ihovaahto - 50 mikrog/g + 0,5 mg/g - kalsipotrioli
fludeomap 250 mbq/ml injektioneste, liuos
map medical technologies oy - fludeoxyglucose (18f) - injektioneste, liuos - 250 mbq/ml - fluori(18f)deoksiglukoosi
nicopass lakritsmint 1.5 mg imeskelytabletti
pierre fabre medicament - nicotinum resin. - imeskelytabletti - 1.5 mg - nikotiini
wynzora 50 mikrog/g + 0.5 mg/g emulsiovoide
almirall s.a. - betamethasone dipropionate, calcipotriol - emulsiovoide - 50 mikrog/g + 0.5 mg/g - kalsipotrioli
ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
rosuvastatin xiromed 5 mg tabletti, kalvopäällysteinen
medical valley invest ab - rosuvastatin calcium - tabletti, kalvopäällysteinen - 5 mg - rosuvastatiini
rosuvastatin xiromed 10 mg tabletti, kalvopäällysteinen
medical valley invest ab - rosuvastatin calcium - tabletti, kalvopäällysteinen - 10 mg - rosuvastatiini
rosuvastatin xiromed 20 mg tabletti, kalvopäällysteinen
medical valley invest ab - rosuvastatin calcium - tabletti, kalvopäällysteinen - 20 mg - rosuvastatiini
rosuvastatin xiromed 40 mg tabletti, kalvopäällysteinen
medical valley invest ab - rosuvastatin calcium - tabletti, kalvopäällysteinen - 40 mg - rosuvastatiini
penthrox 99.9%, 3 ml inhalaatiohöyry, neste
medical developments ned b.v. - methoxyflurane - inhalaatiohöyry, neste - 99.9%, 3 ml - metoksifluraani